Comparison of endocrine therapy and chemotherapy as different systemic treatment modes for metastatic luminal HER2-negative breast cancer patients —A retrospective study

Comparison of endocrine therapy and chemotherapy as different systemic treatment modes for metastatic luminal HER2-negative breast cancer patients —A retrospective study

PurposeThe purpose of this study was to evaluate endocrine therapy and chemotherapy for first-line, maintenance, and second-line treatment of hormone receptor-positive HER-2-negative metastatic breast cancer (HR+HER-2-MBC) and the relationship between different treatment options and survival.Patient...

Full description

Bibliographic Details
Main Authors: Qiuyue Liu, Juan Qiu, Qianrun Lu, Yujin Ma, Shu Fang, Bing Bu, Lihua Song
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
metastatic breast cancer
chemotherapy
endocrine therapy
systemic treatment modes
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.873570/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.873570/full

Similar Items